CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00005515
NCT00005515N/ACompleted
CompareCT.gov

Mutations, Hormone Therapy (HRT) and Venous Thromboembolism

University of Washington·observational·Posted May 26, 2000·Updated Feb 10, 2016

In Brief

An observational study for Cardiovascular Diseases and 2 related conditions. Completed.

Detailed Summary

To assess the interaction between hormone replacement therapy and the prothrombotic mutations, Factor V Leiden and the recently described prothrombin mutation (20210A) on the incidence of venous thromboembolism (VTE) in a population-based case-control study conducted at Group Health Cooperative of Puget Sound (GHC).

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Venous Thromboembolism, Postmenopause
Countries--
CollaboratorsNational Heart, Lung, and Blood Institute (NHLBI)

Timeline

N/ACompletedFinished
199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 26, 2000
Enrollment StartSep 1, 1998
Study CompletionAug 1, 2003
TodayJul 2, 2026
Posted 26.1 years ago